Brainstorm Cell Therapeutics, Inc.

NASDAQ:BCLI 4:00:00 PM EDT

0.54

+0.01 (+2.60%)

7:47:00 PM EDT: $0.56 +0.02 (+3.18%)

Brainstorm Cell Therapeutics, Inc. Stock, NASDAQ:BCLI

1325 Avenue of Americas, 28th floor, New York, New York 10019

United States of America

Phone: +1.201.488.0460

Number of Employees: 29

http://www.brainstorm-cell.com

Description

Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.